Gland Pharma Limited

Web: glandpharma.com NSE: GLAND BSE: 543245 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

2389 50(-2%)

Near 52W High of 2574

Volume

7L as on 22, Jul

Open

1,900

High

1,820

Low

1,774

2,439

VWAP

2,418

52 Week High

2,574

52 Week Low

1,574

Viand Research Rating

Quality Score

56/100

Growth Score

34/100

Valuation Score

50/100

Momentum Score

70/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

39,404

No. of Shares

16.5

P/E

25.67

P/B

3.09

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.02

ROCE

Profit Growth

Listing Date

20-Nov-20

Promoter Holding

51.83%

FII Holding

7.29%

DII Holding

33.36%

Price Chart

Price Performance

1 Week1%

1 Month12%

3 Months35%

6 Months42%

1 Year20%

YTD42%

Moving Average

5 Day SMA2,472

10 Day SMA2,472

20 Day SMA2,456

30 Day SMA2,381

50 Day SMA2,305

61 Day SMA2,214

80 Day SMA2,101

200 Day SMA1,913

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	2,595	2,505	2,546	2,586
Resistance 2	2,546	2,497	2,516	2,542
Resistance 1	2,514	2,490	2,497	2,505
Pivot Point	2,466	2,482	2,466	2,461
Support 1	2,434	2,475	2,435	2,425
Support 2	2,385	2,468	2,416	2,381
Support 3	2,353	2,460	2,385	2,344

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 51.83%	(0.01) 51.83%	(0.01) 51.83%	(0.01) 51.83%	(0.01) 51.83%	(0.01) 51.83%	(0.01) 51.83%	(-6.01) 51.83%	(0.01) 57.86%	(0.01) 57.86%	(0.01) 57.86%	(0.01) 57.86%	(0.01) 57.86%	(0.01) 57.86%	(0.01) 57.86%	(-0.11) 57.87%	(0.01) 58.00%	(0.01) 58.00%	(0.01) 58.02%
FIIs	(-0.31) 7.29%	(-0.31) 7.58%	(0.51) 7.90%	(0.51) 7.39%	(1.91) 6.90%	(0.61) 5.04%	(-2.41) 4.48%	(3.31) 6.88%	(-0.51) 3.59%	(-0.91) 4.05%	(2.11) 4.91%	(-1.51) 2.80%	(-0.31) 4.33%	(-1.41) 4.67%	(-3.31) 6.10%	(-1.31) 9.41%	(-0.61) 10.72%	(0.31) 11.30%	(0.01) 11.01%
DIIs	(0.41) 33.36%	(0.41) 32.99%	(-0.21) 32.63%	(-0.41) 32.86%	(-1.51) 33.27%	(-0.61) 34.80%	(2.51) 35.37%	(7.61) 32.83%	(1.11) 25.23%	(1.71) 24.17%	(-0.91) 22.45%	(0.11) 23.38%	(0.11) 23.23%	(1.21) 23.13%	(4.61) 21.92%	(4.91) 17.36%	(0.81) 12.46%	(-0.11) 11.66%	(0.01) 11.75%
Public	7.52%	7.62%	7.63%	7.93%	8.00%	8.33%	8.33%	8.46%	13.32%	13.93%	14.78%	15.97%	14.59%	14.35%	14.13%	15.35%	18.82%	19.05%	19.21%
No. of Shareholders	91,500	94,578	97,151	110,671	113,788	121,075	122,358	122,665	122,375	136,021	161,627	181,747	150,578	148,469	127,879	117,339	109,098	109,097	109,326

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	1743	1695	1487	1506	1425	1384	1406	1402	1537	1545	1373	1209	785	938	1044	857	1103	1063	1080	1154
Sales Growth % (YoY)	22.3%	22.5%	5.8%	7.4%	-7.3%	-10.4%	2.4%	16%	95.8%	64.7%	31.5%	41%	-28.8%	-11.8%	-3.3%	-25.7%	24.2%	23.7%	29.9%	30.5%
Sales Growth % (QoQ)	2.8%	14%	-1.3%	5.7%	3%	-1.6%	0.3%	-8.8%	-0.5%	12.5%	13.6%	54%	-16.3%	-10.2%	21.8%	-22.3%	3.8%	-1.6%	-6.4%	-
Expenses	1230	1260	1173	1138	1077	1024	1109	1137	1179	1189	1049	915	617	649	748	587	755	714	704	718
Operating Profit	513	435	314	368	348	360	297	264	359	356	324	294	168	290	297	270	348	349	377	436
OPM %	29	26	21	24	24	26	21	19	23	23	24	24	21	31	28	32	32	33	35	38
Other Income	111	39	84	58	44	58	60	51	42	37	53	38	-18	62	66	74	65	46	51	62
Interest	10	4	8	12	7	23	6	6	10	5	6	5	2	3	2	1	2	1	1	1
Depreciation	109	108	106	101	96	96	94	92	93	105	81	65	38	38	37	35	31	28	26	25
Profit before tax	506	362	284	313	288	299	257	218	298	283	290	261	111	311	324	308	380	366	401	472
Tax %	28	28	35	31	35	32	36	34	35	32	33	26	29	25	26	26	25	25	25	26
Net Profit	367	261	184	215	187	205	164	144	192	192	194	194	79	232	241	229	286	273	302	351
Net Profit Growth % (QoQ)	40.6%	41.8%	-14.4%	15%	-8.8%	25%	13.9%	-25%	-	-1%	-	145.6%	-65.9%	-3.7%	5.2%	-19.9%	4.8%	-9.6%	-14%	-
Net Profit Growth % (YoY)	96.3%	27.3%	12.2%	49.3%	-2.6%	6.8%	-15.5%	-25.8%	143%	-17.2%	-19.5%	-15.3%	-72.4%	-15%	-20.2%	-34.8%	-	-	-	-
TTM Net Profit	1027	847	791	771	700	705	692	722	772	659	699	746	781	988	1029	1090	1212	926	653	0
EPS in Rs	22.26	15.87	11.15	13.08	11.32	12.42	9.93	8.73	11.68	11.65	11.78	11.79	4.78	14.08	14.65	13.92	17.4	16.62	18.39	21.39

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Sales	6431	5616	5665	3625	4401	3463	2633
Sales Growth %	-	-0.8%	56.3%	-17.6%	27.1%	31.5%	-
Expenses	4801	4348	4332	2600	2890	2161	1678
Operating Profit	1630	1269	1333	1025	1510	1302	955
OPM %	25	23	24	28	34	38	36
Other Income	292	214	170	184	224	135	139
Interest	33	42	26	7	5	3	7
Depreciation	424	378	345	147	110	99	95
Profit before tax	1465	1063	1133	1055	1619	1335	993
Tax %	30	34	32	26	25	25	22
Net Profit	1027	699	772	781	1212	997	773
Net Profit Growth %	46.9%	-9.5%	-1.2%	-35.6%	21.6%	29%	-
EPS in Rs	62.35	42.4	46.9	47.42	73.75	60.94	49.88
Dividend Payout %	32	42	43	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash from Operating Activity	1031	915	997	364	791	605	701
Cash from Investing Activity	138	1718	-1749	1211	-999	-1520	-761
Cash from Financing Activity	-417	-433	-799	15	35	1238	-7
Net Cash Flow	752	2199	-1552	1590	-174	323	-67

Balance Sheet

	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Equity Capital	16	16	16	16	16	16	16	16
Reserves	9546	9134	8772	8707	7942	7141	5887	3631
Borrowings	302	314	327	372	4	5	4	5
Other Liabilities	1935	1708	1752	1515	814	671	589	435
Total Liabilities	11800	11173	10867	10611	8778	7834	6496	4086
Fixed Assets	4403	4147	4021	3947	1571	1502	954	968
CWIP	209	151	277	238	177	191	338	188
Investments	0	0	0	0	0	155	0	0
Other Assets	7188	6875	6569	6426	7030	5986	5204	2929
Total Assets	11800	11173	10867	10611	8778	7834	6496	4086

Delivery

#	Date	1822 41% 2574	Value (Cr)	Q/T 19	Del 46	Del 147
1	22-Jul	2439	162	11	50	81
2	21-Jul	2482	52	11	48	25
3	20-Jul	2459	80	10	59	47
4	17-Jul	2449	80	11	52	42
5	16-Jul	2529	204	13	48	98
6	15-Jul	2465	81	13	67	54
7	14-Jul	2488	122	14	56	68
8	13-Jul	2461	150	14	65	98
9	10-Jul	2479	82	9	50	41
10	9-Jul	2470	89	9	54	48
11	8-Jul	2496	256	10	51	130
12	7-Jul	2550	284	15	38	108
13	6-Jul	2463	131	14	61	79
14	3-Jul	2462	130	9	39	51
15	2-Jul	2446	112	15	73	82
16	1-Jul	2465	133	13	49	66
17	30-Jun	2495	569	17	33	188
18	29-Jun	2373	176	20	59	103
19	25-Jun	2315	131	13	47	62
20	24-Jun	2326	220	14	49	107
21	23-Jun	2298	473	14	43	204
22	22-Jun	2187	117	10	65	77
23	19-Jun	2199	63	10	59	37
24	18-Jun	2202	224	21	71	159
25	17-Jun	2198	186	30	73	136
26	16-Jun	2179	112	11	56	63
27	15-Jun	2213	124	13	46	57
28	12-Jun	2262	159	13	47	74
29	11-Jun	2306	566	14	40	224
30	10-Jun	2268	74	13	42	31
31	9-Jun	2288	119	16	60	72
32	8-Jun	2248	109	12	32	35
33	5-Jun	2273	111	11	43	48
34	4-Jun	2220	46	7	48	22
35	3-Jun	2232	58	12	49	28
36	2-Jun	2277	111	15	63	69
37	1-Jun	2292	135	12	47	63
38	29-May	2250	50	10	53	26
39	27-May	2313	52	11	54	28
40	26-May	2308	202	20	67	136
41	25-May	2334	119	12	41	49
42	22-May	2334	202	23	60	121
43	21-May	2331	234	18	52	123
44	20-May	2222	265	18	33	87
45	19-May	2251	527	16	27	141
46	18-May	2157	1517	18	18	278
47	15-May	1868	27	10	62	16
48	14-May	1898	33	17	62	20

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	39,404c	647c	1.61
22-Jul	40,051c	942c	2.30
21-Jul	40,993c	668c	1.66
17-Jul	40,324c	1,676c	3.99
16-Jul	42,000c	1,344c	3.31
15-Jul	40,656c	190c	0.46
14-Jul	40,846c	210c	0.52
13-Jul	40,636c	991c	2.38
10-Jul	41,628c	957c	2.35
09-Jul	40,671c	569c	1.38
08-Jul	41,240c	874c	2.08
07-Jul	42,114c	1,234c	3.02
06-Jul	40,880c	503c	1.25
02-Jul	40,377c	409c	1.00
30-Jun	40,786c	1,811c	4.65
29-Jun	38,975c	820c	2.15
26-Jun	38,155c	74c	0.19
25-Jun	38,081c	337c	0.88
24-Jun	38,418c	708c	1.88
23-Jun	37,710c	1,669c	4.63
22-Jun	36,040c	211c	0.58
19-Jun	36,252c	35c	0.10
17-Jun	36,286c	424c	1.18
16-Jun	35,862c	561c	1.54
15-Jun	36,423c	779c	2.09
12-Jun	37,202c	1,651c	4.25
11-Jun	38,853c	1,160c	3.08
10-Jun	37,693c	0	0

Stock Checklist

Price is above from 52 week high low average: 63%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 228 fund scheme(s) across 27 fund house(s) as of Jul26 · Total value ₹19,181 Cr · 70 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
HDFC Mutual Fund	30	1.69%	+0.33%	4970.6
Mirae Asset Mutual Fund	18	2.69%	-	3838.4
Nippon India Mutual Fund	16	0.97%	-	2865.4
SBI Mutual Fund	13	21.56%	+0.04%	1864.2
ICICI Prudential Mutual Fund	14	1.78%	+0.15%	1395.4
DSP Mutual Fund	16	7.35%	-	928
UTI Mutual Fund	8	0.90%	-	680.5
Sundaram Mutual Fund	8	1.11%	+0.06%	587.8
quant Mutual Fund	4	70.66%	-	491.8
Aditya Birla Sun Life Mutual Fund	10	0.69%	-	460.8
Axis Mutual Fund	14	0.66%	-	379
Canara Robeco Mutual Fund	4	1.04%	-	310
WhiteOak Capital Mutual Fund	14	27.76%	+0.77%	263.2
Kotak Mahindra Mutual Fund	6	2.37%	+0.51%	42.6
Mahindra Manulife Mutual Fund	4	0.62%	+0.18%	22.2
Baroda BNP Paribas Mutual Fund	2	2.09%	-	22.2
Motilal Oswal Mutual Fund	8	34.65%	-	21.5
Tata Mutual Fund	4	1.69%	-	9.7
LIC Mutual Fund	6	1.48%	-	8.7
Edelweiss Mutual Fund	4	0.85%	-	6
Groww Mutual Fund	6	3.06%	-	4.1
Samco Mutual Fund	2	1.14%	+1.14%	3.6
Jio BlackRock Mutual Fund	2	0.40%	-	2.5
Bandhan Mutual Fund	6	0.59%	-	1.6
Navi Mutual Fund	6	1.71%	-	1.1
Angel One Mutual Fund	2	0.07%	-	0.1
Zerodha Mutual Fund	1	0.45%	+0.08%	0

Gland Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements